On August 24, 2021, the U.S. Preventive Services Task Force (USPSTF) revised their recommendations for type 2 diabetes and pre-diabetes screening. The revision includes a recommendation that screening of all overweight and obese adults should begin at age 35 rather than age 40, per their previous recommendation in 2015.
Asthma is one of the most common conditions we see in primary care and can result in significant morbidity and mortality if not diagnosed and managed optimally. The National Heart, Lung, and Blood Institute (NHLBI) has sponsored a consensus panel to develop clinical practice guidelines for child and adult asthma since 1989. The guidelines were updated at the end of 2020 for the first time in over a decade.